​​The 29th Annual

​Contemporary Issues in Urology

presented by Loma Linda University & the University of Southern California

Overall Learning Objectives


  • Understand the role of adjuvant therapy in cancer

  • Understand the role of emerging technologies in treating prostate cancer

  • Understand MRI findings significant for prostate cancer and the role of MRI in diagnosing/staging prostate cancer

  • Understand the indications and ideal patient for male sling for post prostatectomy urinary incontinence

  • Understand the indications for female sling for stress urinary incontinence and how to address potential complications

  • Better understand risks and appropriateness of radiologic studies with ionizing radiation

  • Identify practical methods to reduce radiation exposure in fluoroscopy to yourself and patients

  • Understand the methods available to endoscopically address BPH

  • Understand and manage the complications that arise in complex reconstructive transgender surgeries

  • Understand the complexities and indications of antibiotic utilization

  • Review and understand the current health policies that are impacting urology providers and access to care 

_________________________________________________________________________

Accreditation Statement

The Loma Linda University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Loma Linda University School of Medicine designates this Live Activity for a maximum of 12.5 AMA PRA Category 1 Credit(s)
TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Disclosures

This program has been planned and implemented in accordance with ACCME essentials and standards.  The Loma Linda University School of Medicine Office of Continuing Medical Education relies on its CME faculty to provide program content that is free of commercial bias.  Therefore, in accordance with ACCME standards, any faculty and/or provider industry relationships will be disclosed and resolved.